Frequently Asked Questions

1. What is the MedicineInsight program, and what data does it collect?

2. What is the size of the dataset obtained under the 2019-2024 NHMRC grant?

3. What format is used to organize the dataset, and what standards are followed? 

4. What types of information do the OMOP-CDM tables contain? 

5. How has patient privacy been safeguarded in the dataset?

6. How does the dataset contribute to advancements in healthcare? 

7. Who has approved access to the MedicineInsight dataset?

8. Can the dataset be used for various research purposes? 

9. Can the dataset be used to report on the distance between a patient's residence and their GP practice? 

     10. Is ethics approval required to access the data? And what is the typical timeframe for approval?